Trulicity (dulaglutide) is a once-weekly prescription injection FDA-approved for the treatment of type 2 diabetes in adults
Heres what you need to know before deciding if theyre right for you
Crucially, more clinical studies are required to definitively establish the efficacy and safety of GLP-1 RAs for the treatment of ALD and MetALD
Isolation of cardiomyocytes, endothelial cells, and fibroblasts from mouse hearts ECs, FBs, and CMs were isolated from mouse hearts as previously described, with modifications 62
( Figure 5 ) Briefly, SGLT2i inhibits the SGLT receptors in the proximal tubule, which inhibits the reabsorption of glucose from primary urine, resulting in glycosuria and a decrease in HbA1c and fasting glucose levels ( Figure 5 Clinical implications Given the significant cardioprotective effect of SGLT2i and GLP-1RAs, the ADA guidelines state that all diabetic patients with confirmed or subclinical cardiovascular disease should be prescribed a GLP-1RA class or SGLT2i class with proven cardiovascular benefit, regardless of the patients HbA1c level or the presence of other glucose-lowering medications ( Strengths and limitations To the best of our knowledge, this is the first meta-analysis to assess the effects of SGLT2i and GLP-1RAs as first-line therapeutic agents in T2DM patients with low cardiovascular disease risk
During my second O-Shot, Dr
